Study Evaluating Rhapsody Registry in Patients With Depre... | NCT00241397 | Trialant

Home
Search
Collections
Views
Audits

Terms of Service
Privacy Policy

Study Evaluating Rhapsody Registry in Patients With Depre... | NCT00241397 | Trialant

Studies
Study Evaluating Rhapsody Registry in Patients With Depression and Anxiety

NCT00241397

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer

Status

Completed

Last Update Posted

Mar 15, 2007Estimated

Enrollment

2,560

Phase

Not provided

Conditions

Pain
Depression
Anxiety Disorder

Interventions

Not provided

Countries

Belgium

Protocol Section

Identification Module Status Module Sponsor/Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms/Interventions Module Outcomes Module Eligibility Module Contacts/Locations Module References Module IPD Sharing Statement Module

Results Section

Participant Flow Module Baseline Characteristics Module Outcome Measures Module Adverse Events Module More Info Module

Annotation Section

Annotation Module

Document Section

Large Document Module

Derived Section

Miscellaneous Info Module Condition Browse Module Intervention Browse Module

Protocol Section

Identification Module

NCT ID

NCT00241397

Obsolete or Duplicate NCT IDs

Not provided

Organization Study

0600B1-102003

Secondary IDs

Not provided

Brief Title

Study Evaluating Rhapsody Registry in Patients With Depression and Anxiety

Official Title

An Observational Study on the Presence of Depression and/or Anxiety Disorder in Patients Consulting the General Practitioner With Painful Physical Symptoms in Belgium and Luxemburg.

Acronym

Not provided

Organization

Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY

Status Module

Record Verification Date

Mar 2007

Overall Recruitment Status or Expanded Access Status

Completed

Last Known Status

Not provided

Delayed Posting

Not provided

Why Stopped

Not provided

Expanded Access Info

No

Start Date

Nov 2005

Primary Completion Date

Not provided

Completion Date

Not provided

First Submitted Date

Oct 17, 2005

First Submission Date that Met QC Criteria

Oct 17, 2005

First Posted Date

Oct 18, 2005Estimated

Results Waived

Not provided

Results First Submitted Date

Not provided

Results First Submitted that Met QC Criteria

Not provided

Results First Posted Date

Not provided

Certification/Extension (aka Delayed Results) First Submitted Date

Not provided

Certification/Extension First Submitted that Passed QC Review

Not provided

Certification/Extension First Posted Date

Not provided

Last Update Submitted Date

Mar 14, 2007

Last Update Posted Date

Mar 15, 2007Estimated

Sponsor/Collaborators Module

Responsible Party, by Official Title

Not provided

Lead Sponsor

Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY

Collaborators

Not provided

Oversight Module

No data available

No data is available for this block.

Description Module

Brief Summary

The purpose of this study is to assess the prevalence of Major Depression and/or Anxiety Disorder in patients consulting the General Practitioner with acute or chronic painful physical symptoms and to identify risk factors.

Detailed Description

Not provided

Conditions Module

Conditions

Pain
Depression
Anxiety Disorder

Keywords

pain
depression
anxiety disorder

Design Module

Study Type

Observational

Number of References to an Expanded Access Study

Not provided

Expanded Access Types

Not provided

Patient Registry

Not provided

Target Follow-Up Duration

Not provided

Phases

Not provided

Interventional Study Design

Allocation

Not provided

Intervention Model

Biospecimen

No data available

No data is available for this block.

Enrollment

2,560

Arms/Interventions Module

No data available

No data is available for this block.

Outcomes Module

No data available

No data is available for this block.

Eligibility Module

Eligibility Criteria

Inclusion Criteria:

Outpatient must be at least 18 years of age
Consulting a General Practitioner for painful physical symptoms
Written informed consent

Exclusion Criteria:

Patient is unable to understand and comply with procedures of the study
Patient is unable to complete the patient ratings
Patient has an acute pain with an obvious cause

Accepts Healthy Volunteers

No

Sex

All

Sex/Gender Based

Not provided

Sex/Gender Description

Not provided

Minimum Age

18 Years

Maximum Age

Not provided

Standard Ages

AdultOlder Adult

Study Population

Not provided

Sampling Method

Not provided

Contacts/Locations Module

Central Contacts

Not provided

Overall Officials

Name	Affiliation	Role
Medical Monitor, MD	Wyeth is now a wholly owned subsidiary of Pfizer	Study Director
Trial Manager	For Belgium, trials-BEL@wyeth.com	Principal Investigator

Locations

Facility	Status	City	State	ZIP	Country	Contacts
		Aarschot		3200	Belgium

References Module

No data available

No data is available for this block.

IPD Sharing Statement Module

No data available

No data is available for this block.

Results Section

No data available

No data is available for this block.

Annotation Section

No data available

No data is available for this block.

Document Section

No data available

No data is available for this block.

Derived Section

Miscellaneous Info Module

Version Holder

Jul 10, 2026

Removed Countries

Not provided

Submission Tracking

No data available

No data is available for this block.

Condition Browse Module

MeSH Terms

Intervention Browse Module

No data available

No data is available for this block.

Not provided

Intervention Model Description

Not provided

Primary Purpose

Not provided

Observational Model

Defined Population

Time Perspective

Other

Masking Info

No data available

No data is available for this block.

Aiseau-Presles

6250

Belgium

Anderlues

6150

Belgium

Andrimont

4821

Belgium

Angleur

4031

Belgium

Ans

4430

Belgium

Anthée

5520

Belgium

Auvelais

5060

Belgium

Avelgem

8581

Belgium

Beauraing

5570

Belgium

Beernem

8730

Belgium

Bekegem-Ichtegem

8480

Belgium

Belgrade

5001

Belgium

Bertogne

6687

Belgium

Betekom

3130

Belgium

Bierges

1301

Belgium

Binche

7130

Belgium

Bioul

5537

Belgium

Braine-l'Alleud

1420

Belgium

Bruges

8000

Belgium

Bruges

8200

Belgium

Brussels

1040

Belgium

Brussels

1050

Belgium

Brussels

1080

Belgium

Brussels

1083

Belgium

Brussels

1090

Belgium

Brussels

1130

Belgium

Brussels

1140

Belgium

Brussels

1180

Belgium

Brussels

1200

Belgium

Charleroi

6000

Belgium

Ciney

5590

Belgium

Couillet

6010

Belgium

Deurne (Antwerpen)

2100

Belgium

Dworp

1653

Belgium

Eupen

4700

Belgium

Éghezée

5310

Belgium

Galmaarden

1570

Belgium

Goutroux

6030

Belgium

Grimminge

9506

Belgium

Hatrival

6870

Belgium

Hemiksem

2620

Belgium

Herenthout

2270

Belgium

Hoboken

2660

Belgium

Houdeng-Aimeries

7110

Belgium

Houdeng-Goegnies

7110

Belgium

Incourt

1315

Belgium

Itegem

2222

Belgium

Jabbeke

8490

Belgium

Jambes

5100

Belgium

Jodoigne

1370

Belgium

Kapellen

2950

Belgium

Kettenis

4701

Belgium

Klemskerke

8420

Belgium

Kuurne

8520

Belgium

Laarne

9270

Belgium

Lasne

1380

Belgium

Leuven

3000

Belgium

Lobbes

6540

Belgium

Luttre

6238

Belgium

Merksem

2170

Belgium

Mélin

1370

Belgium

Monceau-sur-Sambre

6031

Belgium

Morlanwelz-Mariemont

7140

Belgium

Moustier S/S

5190

Belgium

Noorderwijk

2200

Belgium

Oudenaarde

9700

Belgium

Ranst

2520

Belgium

Rèves

6312

Belgium

Rixensart

1330

Belgium

Romsée

4624

Belgium

Rotselaar

3110

Belgium

Ruddervoorde

8020

Belgium

Sainte-Marie-sur-Semois

6740

Belgium

Schildewindeke

9860

Belgium

Schoten

2900

Belgium

St-Joris Winge

3390

Belgium

Steenokkerzeel

1820

Belgium

Waarschoot

9950

Belgium

Waha

6900

Belgium

Walem

2800

Belgium

Wavre

1300

Belgium

Wetteren

9230

Belgium

Wevelgem

8560

Belgium

Wilrijk

2610

Belgium

Wommelgem

2160

Belgium

Wondelgem

9032

Belgium

Wuustwezel-Gooreind

2990

Belgium

Zelzate

9060

Belgium

Zemst

1980

Belgium

Zétrud-Lumay

1370

Belgium

ID	Term
D010146	Pain
D003863	Depression
D001008	Anxiety Disorders

Ancestor Terms

ID	Term
D009461	Neurologic Manifestations
D012816	Signs and Symptoms
D013568	Pathological Conditions, Signs and Symptoms
D001526	Behavioral Symptoms
D001519	Behavior
D001523	Mental Disorders

Browse Leaves

Not provided

Browse Branches

Not provided